ASO Author Reflections: Adjuvant Therapy for Resectable Pancreatic Cancer in the Real World-Not as Common as One Might Think

Ann Surg Oncol. 2024 May;31(5):2959-2960. doi: 10.1245/s10434-024-15014-4. Epub 2024 Feb 13.

Authors

Salvatore Paiella¹, Giuseppe Malleo², Fabio Casciani², Roberto Salvia²

Affiliations

¹ Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital Trust, Verona, Italy. salvatore.paiella@univr.it.
² Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.

PMID: 38349565
DOI: 10.1245/s10434-024-15014-4

No abstract available

MeSH terms

Combined Modality Therapy
Humans
Pancreatic Neoplasms* / surgery